男性癌症之后的第二个癌症

L. Geranpayeh, E. Rahimpour
{"title":"男性癌症之后的第二个癌症","authors":"L. Geranpayeh, E. Rahimpour","doi":"10.2174/1573394718666220720103303","DOIUrl":null,"url":null,"abstract":"\n\nBreast cancer is relatively rare in men; however, the overall prevalence of breast cancer in men is steadily increasing. Due to the increasing prevalence of the disease, the final consequences of these patients have become more important. One of the major adverse outcomes in surviving patients is secondary cancer following primary breast cancer. The aim of this study was to evaluate the second cancer in men who have survived primary breast cancer. The risk of developing primary second cancers is higher in men with primary breast cancer than in women. Few studies have evaluated the risk of secondary cancers, other than breast cancer, in men with breast cancer. Men who had a history of breast cancer are 10 to 20 times more likely to develop second breast cancer than women, which increases with aging. The association of prostate and breast cancer in the family has been suggested in specific populations, and some studies have shown an increase in prostate cancer in men surviving breast cancer. Lung cancer has also increased in men after breast cancer, but the risk is lower than in women, which is affected by age and gender survival. Melanoma is the second cancer in older survivor men of certain races after one year of follow-up. Gastric cancer after breast cancer showed an increasing prevalence in younger men and surviving more than ten years and familial accumulation of cancer. Pancreatic cancer also increased in men with a family history of breast cancer and mutated genes after primary breast cancer. The risk of second cancer in men with primary breast cancer, like the first cancer, is multifactorial, and genetic and environmental factors can influence its prevalence. Therefore, more extensive research is needed to better understanding of interrelationship of etiological factors and to provide screening and early detection strategies in affected men.\n","PeriodicalId":43754,"journal":{"name":"Current Cancer Therapy Reviews","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2022-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Second Cancer after Breast Cancer in Men\",\"authors\":\"L. Geranpayeh, E. Rahimpour\",\"doi\":\"10.2174/1573394718666220720103303\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nBreast cancer is relatively rare in men; however, the overall prevalence of breast cancer in men is steadily increasing. Due to the increasing prevalence of the disease, the final consequences of these patients have become more important. One of the major adverse outcomes in surviving patients is secondary cancer following primary breast cancer. The aim of this study was to evaluate the second cancer in men who have survived primary breast cancer. The risk of developing primary second cancers is higher in men with primary breast cancer than in women. Few studies have evaluated the risk of secondary cancers, other than breast cancer, in men with breast cancer. Men who had a history of breast cancer are 10 to 20 times more likely to develop second breast cancer than women, which increases with aging. The association of prostate and breast cancer in the family has been suggested in specific populations, and some studies have shown an increase in prostate cancer in men surviving breast cancer. Lung cancer has also increased in men after breast cancer, but the risk is lower than in women, which is affected by age and gender survival. Melanoma is the second cancer in older survivor men of certain races after one year of follow-up. Gastric cancer after breast cancer showed an increasing prevalence in younger men and surviving more than ten years and familial accumulation of cancer. Pancreatic cancer also increased in men with a family history of breast cancer and mutated genes after primary breast cancer. The risk of second cancer in men with primary breast cancer, like the first cancer, is multifactorial, and genetic and environmental factors can influence its prevalence. Therefore, more extensive research is needed to better understanding of interrelationship of etiological factors and to provide screening and early detection strategies in affected men.\\n\",\"PeriodicalId\":43754,\"journal\":{\"name\":\"Current Cancer Therapy Reviews\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2022-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Cancer Therapy Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573394718666220720103303\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Cancer Therapy Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573394718666220720103303","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

乳腺癌在男性中相对罕见;然而,男性乳腺癌的总体患病率正在稳步上升。由于这种疾病的发病率越来越高,这些患者的最终后果变得更加重要。存活患者的主要不良后果之一是原发性乳腺癌后继发癌症。这项研究的目的是评估原发性乳腺癌患者的第二种癌症。患原发性乳腺癌的男性患原发性第二癌的风险高于女性。很少有研究对男性乳腺癌患者继发性癌症(乳腺癌除外)的风险进行评估。有乳腺癌病史的男性患第二次乳腺癌的可能性是女性的10到20倍,这种可能性随着年龄的增长而增加。在特定的人群中,前列腺癌和乳腺癌的家族关联已经被提出,一些研究表明,在乳腺癌幸存的男性中,前列腺癌的发病率有所增加。乳腺癌之后,男性患肺癌的风险也有所增加,但风险低于女性,这受年龄和性别生存的影响。经过一年的随访,黑色素瘤是某些种族的老年幸存者的第二种癌症。胃癌继发于乳腺癌的发病率在年轻男性中呈上升趋势,存活时间在10年以上的男性中呈上升趋势,家族性癌症蓄积。有乳腺癌家族史和原发性乳腺癌后基因突变的男性患胰腺癌的几率也会增加。原发性乳腺癌男性患第二种癌症的风险与第一种癌症一样,是多因素的,遗传和环境因素可以影响其患病率。因此,需要进行更广泛的研究,以更好地了解病因的相互关系,并为受影响的男性提供筛查和早期发现策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Second Cancer after Breast Cancer in Men
Breast cancer is relatively rare in men; however, the overall prevalence of breast cancer in men is steadily increasing. Due to the increasing prevalence of the disease, the final consequences of these patients have become more important. One of the major adverse outcomes in surviving patients is secondary cancer following primary breast cancer. The aim of this study was to evaluate the second cancer in men who have survived primary breast cancer. The risk of developing primary second cancers is higher in men with primary breast cancer than in women. Few studies have evaluated the risk of secondary cancers, other than breast cancer, in men with breast cancer. Men who had a history of breast cancer are 10 to 20 times more likely to develop second breast cancer than women, which increases with aging. The association of prostate and breast cancer in the family has been suggested in specific populations, and some studies have shown an increase in prostate cancer in men surviving breast cancer. Lung cancer has also increased in men after breast cancer, but the risk is lower than in women, which is affected by age and gender survival. Melanoma is the second cancer in older survivor men of certain races after one year of follow-up. Gastric cancer after breast cancer showed an increasing prevalence in younger men and surviving more than ten years and familial accumulation of cancer. Pancreatic cancer also increased in men with a family history of breast cancer and mutated genes after primary breast cancer. The risk of second cancer in men with primary breast cancer, like the first cancer, is multifactorial, and genetic and environmental factors can influence its prevalence. Therefore, more extensive research is needed to better understanding of interrelationship of etiological factors and to provide screening and early detection strategies in affected men.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
50
期刊介绍: Current Cancer Therapy Reviews publishes frontier reviews on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.
期刊最新文献
Understanding the Challenges Associated with Approval of Anticancer Products to Facilitate the Regulatory Approvals: A Cross-sectional Study Bibliometric Analysis to Improve Combined Treatment Strategies for Glioblastoma in America Odor generation pattern of swine manure according to the processing form of feed. Childhood Heart Tumors: Detection, Diagnosis, and Treatments Metformin (The Miracle Drug) Kinetics in Different Diseases such as Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1